Chenxi Liu Jie Shao Yanbing Dong Qiuping Xu Zhengyun Zou Fangjun Chen Jing Yan Juan Liu Shuangshuang Li Baorui Liu Jie Shen
10.3389/fimmu.2021.685126
Front Immunol
2021 Jul 13;12:685126.
benefit hepatocellular carcinoma immunotherapy neoantigen reactive t cells tomotherapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34326839/
Antigens, Neoplasm / immunology Carcinoma, Hepatocellular / therapy Liver Neoplasms / therapy T-Lymphocytes / immunology
Antigens, Neoplasm / immunology Carcinoma, Hepatocellular / therapy Liver Neoplasms / therapy T-Lymphocytes / immunology Case Reports Research Support, Non-U.S. Gov't Aged Carcinoma, Hepatocellular / immunology Humans Immunotherapy Liver Neoplasms / immunology Male Prognosis Antigens, Neoplasm
PMC8315135
34326839
Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report
2021